Venetoclax and hypomethylating agents yield high response rates and favourable transplant outcomes in patients with newly diagnosed acute myeloid leukaemia. (21st December 2021) - Salhotra, Amandeep; Tsai, Ni‐Chun; Zhang, Jianying; Ngo, Dat; Aribi, Ahmed; Sandhu, Karamjeet; Ball, Brian; Al‐Malki, Monzr; Ali, Haris; Koller, Paul; Artz, Andrew; Forman, Stephen; et al.